Safety of NR-INF-02, an Extract of Curcuma Longa Containing Turmerosaccharides, in Healthy Volunteers: A Randomized, Open-label Clinical Trial.
Conclusion: The study found NR-INF-02 to be safe and tolerable at both tested doses for the given duration of the trial for healthy adult volunteers.
PMID: 32827412 [PubMed - as supplied by publisher]
Source: Alternative Therapies in Health and Medicine - Category: Complementary Medicine Authors: Selvi M, Mohan Mv R, Bethapudi B, Mundkinajeddu D, Kumari S Tags: Altern Ther Health Med Source Type: research
More News: Alternative and Complementary Therapies | Antidoxidants | Arthritis | Clinical Trials | Complementary Medicine | Electrocardiogram | Hematology | Herbs | India Health | Laboratory Medicine | Rheumatology | Study | Turmeric | Urology & Nephrology | Women